Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INSP Inspire Medical Systems	$95.80 +4.6%	$117.55	$73.92 ▼ $225.00	$2.71B	1.22	1.66 million shs	559,798 shs
LQDA Liquidia Technologies	$26.84 -1.7%	$17.51	$8.75 ▼ $28.00	$2.35B	0.14	3.26 million shs	2.60 million shs
PRCT PROCEPT BioRobotics	$41.23 +4.8%	$52.59	$37.12 ▼ $103.81	$2.19B	1.05	1.58 million shs	727,270 shs
SIBN SiBone	$16.39 +4.8%	$17.06	$11.70 ▼ $20.05	$674.72M	0.91	509,321 shs	333,628 shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INSP Inspire Medical Systems	+4.40%	+9.27%	-27.35%	-33.12%	-48.86%
LQDA Liquidia Technologies	-1.68%	+3.43%	+51.21%	+74.85%	+168.94%
PRCT PROCEPT BioRobotics	+4.78%	-0.87%	-31.35%	-28.15%	-50.59%
SIBN SiBone	+4.80%	+6.02%	-7.71%	-10.83%	+8.61%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
INSP Inspire Medical Systems	4.9394 of 5 stars	4.3	4.0	4.8	3.9	1.7	1.9
LQDA Liquidia Technologies	3.5293 of 5 stars	3.5	3.0	0.0	2.9	4.2	0.6
PRCT PROCEPT BioRobotics	3.5406 of 5 stars	4.4	1.0	0.0	4.0	2.5	0.6
SIBN SiBone	4.1725 of 5 stars	3.5	4.0	3.3	1.1	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
INSP Inspire Medical Systems	2.54	Moderate Buy	$165.62	72.88% Upside
LQDA Liquidia Technologies	3.00	Buy	$32.11	19.64% Upside
PRCT PROCEPT BioRobotics	2.78	Moderate Buy	$74.88	81.60% Upside
SIBN SiBone	3.00	Buy	$23.67	44.40% Upside

Current Analyst Ratings Breakdown

Latest SIBN, INSP, PRCT, and LQDA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/15/2025	INSP Inspire Medical Systems	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$116.00 ➝ $97.00
8/15/2025	LQDA Liquidia Technologies	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$43.00
8/13/2025	LQDA Liquidia Technologies	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Strong-Buy ➝ Strong-Buy	$33.00 ➝ $41.00
8/13/2025	LQDA Liquidia Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$25.00 ➝ $31.00
8/12/2025	LQDA Liquidia Technologies	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$32.00 ➝ $36.00
8/11/2025	SIBN SiBone	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Overweight	$25.00
8/7/2025	PRCT PROCEPT BioRobotics	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$75.00 ➝ $58.00
8/7/2025	PRCT PROCEPT BioRobotics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$80.00 ➝ $55.00
8/5/2025	INSP Inspire Medical Systems	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$270.00 ➝ $150.00
8/5/2025	INSP Inspire Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$174.00 ➝ $101.00
8/5/2025	INSP Inspire Medical Systems	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$270.00 ➝ $230.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
INSP Inspire Medical Systems	$802.80M	3.53	$1.79 per share	53.62	$22.92 per share	4.18
LQDA Liquidia Technologies	$14M	165.05	N/A	N/A	$0.18 per share	149.11
PRCT PROCEPT BioRobotics	$224.50M	10.22	N/A	N/A	$6.93 per share	5.95
SIBN SiBone	$167.18M	4.23	N/A	N/A	$3.95 per share	4.15

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
INSP Inspire Medical Systems	$53.51M	$1.73	55.37	29.75	2.86	6.17%	10.38%	8.93%	11/3/2025 (Estimated)
LQDA Liquidia Technologies	-$130.39M	-$1.70	N/A	N/A	N/A	-732.17%	-232.96%	-60.81%	N/A
PRCT PROCEPT BioRobotics	-$91.41M	-$1.55	N/A	N/A	N/A	-30.60%	-23.73%	-17.34%	10/27/2025 (Estimated)
SIBN SiBone	-$30.91M	-$0.56	N/A	N/A	N/A	-12.83%	-14.20%	-10.38%	11/11/2025 (Estimated)

Latest SIBN, INSP, PRCT, and LQDA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	LQDA Liquidia Technologies	-$0.43	-$0.49	-$0.06	-$0.49	$3.90 million	$8.84 million
8/6/2025	Q2 2025	PRCT PROCEPT BioRobotics	-$0.41	-$0.35	+$0.06	-$0.35	$75.67 million	$79.18 million
8/4/2025	Q2 2025	INSP Inspire Medical Systems	$0.22	$0.45	+$0.23	-$0.12	$214.50 million	$217.09 million
8/4/2025	Q2 2025	SIBN SiBone	-$0.19	-$0.14	+$0.05	-$0.14	$48.12 million	$48.63 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A
LQDA Liquidia Technologies	N/A	N/A	N/A	N/A	N/A
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A
SIBN SiBone	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
INSP Inspire Medical Systems	N/A	6.14	4.84
LQDA Liquidia Technologies	9.84	2.49	2.41
PRCT PROCEPT BioRobotics	0.13	9.21	7.86
SIBN SiBone	0.21	8.38	7.00

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
INSP Inspire Medical Systems	94.91%
LQDA Liquidia Technologies	64.54%
PRCT PROCEPT BioRobotics	89.46%
SIBN SiBone	98.11%

Insider Ownership

Company	Insider Ownership
INSP Inspire Medical Systems	4.10%
LQDA Liquidia Technologies	26.50%
PRCT PROCEPT BioRobotics	6.60%
SIBN SiBone	4.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
INSP Inspire Medical Systems	1,246	29.57 million	28.36 million	Optionable
LQDA Liquidia Technologies	50	86.09 million	63.28 million	Optionable
PRCT PROCEPT BioRobotics	430	55.64 million	51.96 million	Optionable
SIBN SiBone	350	43.14 million	41.42 million	Optionable

SIBN, INSP, PRCT, and LQDA Headlines

Recent News About These Companies

American Century Companies Inc. Purchases 264,254 Shares of SiBone $SIBN

August 23 at 4:43 AM | marketbeat.com

1,326,100 Shares in SiBone $SIBN Acquired by Nuveen LLC

August 22 at 3:47 AM | marketbeat.com

SiBone (NASDAQ:SIBN) SVP Sells $52,065.56 in Stock

August 21 at 8:54 AM | insidertrades.com

Tocqueville Asset Management L.P. Has $3.58 Million Stake in SiBone (NASDAQ:SIBN)

August 19, 2025 | marketbeat.com

SiBone (NASDAQ:SIBN) Director John Gordon Freund Sells 12,132 Shares

August 12, 2025 | marketbeat.com

Insider Selling: SiBone (NASDAQ:SIBN) Director Sells 12,132 Shares of Stock

August 12, 2025 | insidertrades.com

SiBone (NASDAQ:SIBN) Stock Rating Lowered by Wall Street Zen

August 10, 2025 | marketbeat.com

FY2025 EPS Estimates for SiBone Boosted by Cantor Fitzgerald

August 9, 2025 | marketbeat.com

SiBone (NASDAQ:SIBN) Shares Down 13.1% - Here's What Happened

August 6, 2025 | marketbeat.com

SiBone (NASDAQ:SIBN) Earns "Overweight" Rating from Cantor Fitzgerald

August 6, 2025 | marketbeat.com

SiBone (NASDAQ:SIBN) Issues Quarterly Earnings Results

August 5, 2025 | marketbeat.com

SI-Bone Reports Strong Q2 2025 Financial Results

August 5, 2025 | msn.com

SI-BONE, Inc. (SIBN) Q2 2025 Earnings Call Transcript

August 5, 2025 | seekingalpha.com

SI-BONE, Inc. 2025 Q2 - Results - Earnings Call Presentation

August 4, 2025 | seekingalpha.com

Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates

August 4, 2025 | zacks.com

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance

August 4, 2025 | globenewswire.com

Universal Beteiligungs und Servicegesellschaft mbH Acquires New Holdings in SiBone (NASDAQ:SIBN)

August 3, 2025 | marketbeat.com

SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025

July 29, 2025 | globenewswire.com

SiBone (SIBN) Projected to Post Quarterly Earnings on Monday

July 28, 2025 | marketbeat.com

Victory Capital Management Inc. Raises Stock Holdings in SiBone (NASDAQ:SIBN)

July 25, 2025 | marketbeat.com

Legato Capital Management LLC Acquires 36,649 Shares of SiBone (NASDAQ:SIBN)

July 24, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SIBN, INSP, PRCT, and LQDA Company Descriptions

Inspire Medical Systems NYSE:INSP

$95.80 +4.18 (+4.56%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$96.01 +0.21 (+0.22%)

As of 08/22/2025 07:41 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Liquidia Technologies NASDAQ:LQDA

$26.84 -0.46 (-1.68%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$26.92 +0.09 (+0.32%)

As of 08/22/2025 07:52 PM Eastern

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

PROCEPT BioRobotics NASDAQ:PRCT

$41.23 +1.88 (+4.78%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$42.02 +0.79 (+1.92%)

As of 08/22/2025 07:56 PM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

SiBone NASDAQ:SIBN

$16.39 +0.75 (+4.80%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$16.05 -0.34 (-2.07%)

As of 08/22/2025 05:11 PM Eastern

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time